Real-World Outcomes and Prognostic Factors of Polymyxin B Hemoperfusion in Severe Sepsis and Septic Shock: A Seven-Year Single-Center Cohort Study from Taiwan

<b>Background</b>: Severe sepsis and septic shock remain major contributors to ICU mortality. Polymyxin B hemoperfusion (PMX-HP) has been widely adopted as adjunctive therapy in Asian ICUs for endotoxemia, but its real-world effectiveness and prognostic factors remain uncertain, especially in high G...

詳細記述

書誌詳細

主要な著者:	Wei-Hung Chang, Ting-Yu Hu, Li-Kuo Kuo
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2025-08-01
シリーズ:	Life
主題:	polymyxin B hemoperfusion severe sepsis septic shock intensive care unit endotoxemia APACHE II score
オンライン･アクセス:	https://www.mdpi.com/2075-1729/15/8/1317
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!